Heme oxygenase-1, a critical arbitrator of cell death pathways in lung injury and disease
- PMID: 19362144
- PMCID: PMC3078523
- DOI: 10.1016/j.freeradbiomed.2009.04.007
Heme oxygenase-1, a critical arbitrator of cell death pathways in lung injury and disease
Abstract
Increases in cell death by programmed (i.e., apoptosis, autophagy) or nonprogrammed mechanisms (i.e., necrosis) occur during tissue injury and may contribute to the etiology of several pulmonary or vascular disease states. The low-molecular-weight stress protein heme oxygenase-1 (HO-1) confers cytoprotection against cell death in various models of lung and vascular injury by inhibiting apoptosis, inflammation, and cell proliferation. HO-1 serves a vital metabolic function as the rate-limiting step in the heme degradation pathway and in the maintenance of iron homeostasis. The transcriptional induction of HO-1 occurs in response to multiple forms of chemical and physical cellular stress. The cytoprotective functions of HO-1 may be attributed to heme turnover, as well as to beneficial properties of its enzymatic reaction products: biliverdin-IXalpha, iron, and carbon monoxide (CO). Recent studies have demonstrated that HO-1 or CO inhibits stress-induced extrinsic and intrinsic apoptotic pathways in vitro. A variety of signaling molecules have been implicated in the cytoprotection conferred by HO-1/CO, including autophagic proteins, p38 mitogen-activated protein kinase, signal transducer and activator of transcription proteins, nuclear factor-kappaB, phosphatidylinositol 3-kinase/Akt, and others. Enhanced HO-1 expression or the pharmacological application of HO end-products affords protection in preclinical models of tissue injury, including experimental and transplant-associated ischemia/reperfusion injury, promising potential future therapeutic applications.
Figures


Similar articles
-
Heme oxygenase-1 and gut ischemia/reperfusion injury: A short review.World J Gastroenterol. 2013 Jun 21;19(23):3555-61. doi: 10.3748/wjg.v19.i23.3555. World J Gastroenterol. 2013. PMID: 23801856 Free PMC article. Review.
-
Heme oxygenase-1/carbon monoxide: from metabolism to molecular therapy.Am J Respir Cell Mol Biol. 2009 Sep;41(3):251-60. doi: 10.1165/rcmb.2009-0170TR. Epub 2009 Jul 17. Am J Respir Cell Mol Biol. 2009. PMID: 19617398 Free PMC article. Review.
-
Products of heme oxygenase and their potential therapeutic applications.Am J Physiol Renal Physiol. 2006 Mar;290(3):F563-71. doi: 10.1152/ajprenal.00220.2005. Am J Physiol Renal Physiol. 2006. PMID: 16461755 Review.
-
Heme oxygenase system in ischemia and reperfusion injury.Ann Transplant. 2004;9(1):84-7. Ann Transplant. 2004. PMID: 15478901 Review.
-
Therapeutic Potential of Heme Oxygenase-1/carbon Monoxide System Against Ischemia-Reperfusion Injury.Curr Pharm Des. 2017;23(26):3884-3898. doi: 10.2174/1381612823666170413122439. Curr Pharm Des. 2017. PMID: 28412905 Review.
Cited by
-
TRIM55 Aggravates Cardiomyocyte Apoptosis After Myocardial Infarction via Modulation of the Nrf2/HO-1 Pathway.JACC Basic Transl Sci. 2024 Aug 14;9(9):1104-1122. doi: 10.1016/j.jacbts.2024.05.006. eCollection 2024 Sep. JACC Basic Transl Sci. 2024. PMID: 39444927 Free PMC article.
-
Acid sphingomyelinase inhibition induces cerebral angiogenesis post-ischemia/reperfusion in an oxidative stress-dependent way and promotes endothelial survival by regulating mitochondrial metabolism.Cell Death Dis. 2024 Sep 4;15(9):650. doi: 10.1038/s41419-024-06935-9. Cell Death Dis. 2024. PMID: 39231943 Free PMC article.
-
Heme Oxgenase-1, a Cardinal Modulator of Regulated Cell Death and Inflammation.Cells. 2021 Feb 28;10(3):515. doi: 10.3390/cells10030515. Cells. 2021. PMID: 33671004 Free PMC article. Review.
-
Heme Oxygenase-1 Inhibition Potentiates the Effects of Nab-Paclitaxel-Gemcitabine and Modulates the Tumor Microenvironment in Pancreatic Ductal Adenocarcinoma.Cancers (Basel). 2021 May 8;13(9):2264. doi: 10.3390/cancers13092264. Cancers (Basel). 2021. PMID: 34066839 Free PMC article.
-
Upregulation of Heme Oxygenase-1 by Hemin Alleviates Sepsis-Induced Muscle Wasting in Mice.Oxid Med Cell Longev. 2018 Nov 8;2018:8927104. doi: 10.1155/2018/8927104. eCollection 2018. Oxid Med Cell Longev. 2018. PMID: 30533176 Free PMC article.
References
-
- Ryter SW, Alam J, Choi AM. Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiol. Rev. 2006;86:583–650. - PubMed
-
- Morse D, Choi AM. Heme oxygenase-1: the “emerging molecule” has arrived. Am. J. Respir. Cell Mol. Biol. 2002;27:8–16. - PubMed
-
- Tenhunen R, Marver HS, Schmid R. Microsomal heme oxygenase. Characterization of the enzyme. J. Biol. Chem. 1969;244:6388–6394. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources